Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BDKRB2 known ✓ | P30411 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.56 |
| ▸ | TRAP1 | Q12931 | 2/20 | 0.46 |
| ▸ | CHRNA7 | P36544 | 8/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3181294 | 1.00 | HIF1A (0.56) | HIF1ATRAP1CHRNA7ALDH1A1CYP1A2 | |
| Hydrochloric Acid SCHEMBL716757 | 1.00 | HIF1A (0.56) | HIF1ATRAP1CHRNA7ALDH1A1CYP1A2 | |
| Hydrochloric Acid SCHEMBL3792335 | 1.00 | HIF1A (0.56) | HIF1ATRAP1CHRNA7ALDH1A1CYP1A2 | |
| Hydrochloric Acid SCHEMBL8099653 | 1.00 | HIF1A (0.56) | HIF1ATRAP1CHRNA7ALDH1A1CYP1A2 | |
| Hydrochloric Acid SCHEMBL5084888 | 1.00 | HIF1A (0.56) | HIF1ATRAP1CHRNA7ALDH1A1CYP1A2 | |
| Hydrochloric Acid SCHEMBL5085298 | 1.00 | HIF1A (0.56) | HIF1ATRAP1CHRNA7ALDH1A1CYP1A2 | |
| Hydrochloric Acid SCHEMBL27884199 | 1.00 | HIF1A (0.56) | HIF1ATRAP1CHRNA7ALDH1A1CYP1A2 | |
| Decyltriphenylphosphonium SCHEMBL5087261 | 1.00 | HIF1A (0.56) | HIF1ATRAP1CHRNA7ALDH1A1CYP1A2 | |
| Hydrochloric Acid SCHEMBL5088181 | 1.00 | HIF1A (0.56) | HIF1ATRAP1CHRNA7ALDH1A1CYP1A2 | |
| Hydrochloric Acid SCHEMBL5085239 | 1.00 | HIF1A (0.56) | HIF1ATRAP1CHRNA7ALDH1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025095106-A1 | RESIST UNDERLAYER FILM FORMATION COMPOSITION | 日産化学株式会社 | 2025-05-08 | — | — | WO | disclosed |
| US-20250127898-A1 | PHOTODYNAMIC THERAPY AND DIAGNOSIS | Invion Limited (AU) | 2025-04-24 | — | — | US | disclosed |
| EP-4436973-A1 | PHOTODYNAMIC THERAPY AND DIAGNOSIS | RMW Cho Group Limited (HK) | 2024-10-02 | — | — | EP | disclosed |
| CN-114746468-B | Method for producing polymer | 日产化学株式会社 | 2024-09-13 | — | — | CN | disclosed |
| CN-118591543-A | Photodynamic therapy and diagnosis | RMW曹氏集团有限公司 | 2024-09-03 | — | — | CN | disclosed |
| US-20230365577-A1 | Photodynamic Therapy and Diagnosis | RMW CHO GROUP LIMITED (HK) | 2023-11-16 | — | — | US | disclosed |
| EP-4251627-A1 | PHOTODYNAMIC THERAPY AND DIAGNOSIS | RMW Cho Group Limited (CN) | 2023-10-04 | — | — | EP | disclosed |
| CN-116724043-A | Photodynamic therapy and diagnosis | RMW曹氏集团有限公司 | 2023-09-08 | — | — | CN | disclosed |
| US-11685702-B2 | Method for producing arene compounds and arene compounds produced by the same | JSI SILICONE CO. (KR) | 2023-06-27 | — | — | US | disclosed |
| WO-2023094680-A1 | PHOTODYNAMIC THERAPY AND DIAGNOSIS | RMW CHO GROUP LIMITED (CN) | 2023-06-01 | — | — | WO | disclosed |
| CN-101503508-A | Method for preparing polythiofuran in water-based medium | UNIV BEIJING NORMAL (CN) | 2009-08-12 | — | — | CN | disclosed |
| US-20080214386-A1 | Stability; easily separated from solution; surface treatment of catalyst with Group seven compound; reacting epoxide with carbon dioxide | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2008-09-04 | — | — | US | disclosed |
| EP-1705180-A1 | (Organothiomethyl)chlorosilanes and their preparation methods | Korea Institute of Science and Technology (KR) | 2006-09-27 | — | — | EP | disclosed |
| US-20060211876-A1 | (ORGANOTHIOMETHYL)CHLOROSILANES AND THEIR PREPARATION METHODS | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2006-09-21 | — | — | US | disclosed |
| US-7109367-B1 | (Organothiomethyl)chlorosilanes and their preparation methods | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2006-09-19 | — | — | US | disclosed |
| US-6740766-B2 | USING SMALL AMOUNT OF QUATERNARY ORGANOPHOSPHONIUM SALT; EASILY RECOVERED FOR RECYCLE; HIGH CATALYTIC ACTIVITY EVEN AT LOW TEMPERATURE; LOW COST | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2004-05-25 | — | — | US | disclosed |
| US-20040063983-A1 | PREPARATION OF ORGANOCHLOROSILANES BY THE SILYLATION OF CONJUGATED DIENES WITH TRICHLOROSILANE | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2004-04-01 | — | — | US | disclosed |
| EP-0708077-B1 | Diamino compounds and methods for preparing them | CHISSO CORP (JP) | 2000-12-27 | — | — | EP | disclosed |
| US-5663440-A | Diamino compounds and methods for preparing them | CHISSO CORPORATION (JP) | 1997-09-02 | — | — | US | disclosed |
| EP-0708077-A1 | Diamino compounds and methods for preparing them | CHISSO CORPORATION (JP) | 1996-04-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040063983-A1 | PREPARATION OF ORGANOCHLOROSILANES BY THE SILYLATION OF CONJUGATED DIENES WITH TRICHLOROSILANE | CDC5L, DCLK1, CCRL2 | BDKRB2 2258/4885HIF1A 4530/4885TRAP1 3572/4885 |
| US-20060211876-A1 | (ORGANOTHIOMETHYL)CHLOROSILANES AND THEIR PREPARATION METHODS | ORC3, OXSR1, TST | BDKRB2 2812/4885HIF1A 3930/4885TRAP1 3625/4885 |
| US-20250127898-A1 | PHOTODYNAMIC THERAPY AND DIAGNOSIS | PPOX, VHL, TP53 | BDKRB2 4192/4885HIF1A 320/4885TRAP1 3876/4885 |
| US-11685702-B2 | Method for producing arene compounds and arene compounds produced by the same | PFAS, FRK, AGPAT2 | BDKRB2 4012/4885HIF1A 2300/4885TRAP1 3259/4885 |
| US-20230365577-A1 | Photodynamic Therapy and Diagnosis | PPOX, PPIF, ALAD | BDKRB2 3906/4885HIF1A 635/4885TRAP1 2940/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.